The excellent news: Drug shortages within the US may have declined in 2023 from their current peak between 2010 and 2012.

The unhealthy information: The drug scarcity in 2023 was the very best since 2012.

These findings come from an FDA report back to Congress. It’s placing that the shortages of organic medicines (managed by CBER) have elevated sharply in 2023. The FDA writes that:

The yr 2023 was a difficult yr when it comes to shortages. For instance, the notable enhance in new shortages of CBER-regulated organic merchandise was because of manufacturing points and high quality procedures at one producer that confronted international provide chain points associated to the dearth of sure supplies and elements wanted for manufacturing course of. The FDA has seen that producers in the USA and overseas proceed to expertise high quality points and wrestle with capability constraints.

You possibly can learn the complete report right here.